AGC Biologics and Gore Collaborate on New Protein A-based Purification Technology and Contract Manufacturing Services for Antibody Therapies
12. Dezember 2022 08:37 ET
|
AGC Biologics
Seattle, Dec. 12, 2022 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced a collaboration with W.L....
AGC Biologics Receives Excellence in Innovation and Leadership by Italy's Leading Business News Channel Le Fonti
27. Oktober 2022 03:00 ET
|
AGC Biologics
Milan, Italy, Oct. 27, 2022 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced it received the...
AGC Biologics Honored for Innovations in Cell Line Development
13. Oktober 2022 08:37 ET
|
AGC Biologics
Seattle, Oct. 13, 2022 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced it has been named a 2022...
AGC Biologics and Evax Partner to Advance Promising Equine Allergy Vaccine Candidate
07. September 2022 17:00 ET
|
AGC Biologics
Seattle, Sept. 07, 2022 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced a new partnership with Evax,...
RoosterBio and AGC Biologics Announce Collaboration to Accelerate Manufacturing of Cell and Exosome Therapies
16. August 2022 10:57 ET
|
AGC Biologics
SEATTLE, Aug. 16, 2022 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced today a strategic partnership with...
AGC Biologics Supports Altheia Science’s Gene Therapy Programs
28. Juli 2022 08:00 ET
|
AGC Biologics
SEATTLE, MILAN, July 28, 2022 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced a new partnership with...
AGC Biologics Named Manufacturing Company of the year by American Business Awards
29. Juni 2022 09:09 ET
|
AGC Biologics
SEATTLE, June 29, 2022 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced it was named Company of the...
AGC Biologics Honored as a Top 10 Company for Pharma Quality Assurance
09. Juni 2022 08:22 ET
|
AGC Biologics
SEATTLE, June 09, 2022 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced it has been named a Top 10...
AGC Biologics’ Longmont General Manager, Tony Fraij, Joins Colorado BioScience Association Board of Directors
06. Juni 2022 09:03 ET
|
AGC Biologics
SEATTLE, June 06, 2022 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced the appointment of Tony...
AGC Biologics Invests in New Viral Vector Suspension Capabilities at U.S. Cell & Gene Hub
17. Mai 2022 22:03 ET
|
AGC Biologics
SEATTLE, May 17, 2022 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced it is adding viral vector...